Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2010
10/07/2010WO2010042168A3 Methods for making ethanolamine(s) and ethyleneamine(s) from ethylene oxide and ammonia, and related methods
10/07/2010US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
10/07/2010US20100256249 Method for producing polyester type flexible polyurethane foam, and catalyst composition to be used therefor
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/06/2010EP2236498A1 Phenyl acetamide derivative
10/06/2010EP2234987A2 Perhydroquinoxaline derivatives as analgesics
10/06/2010EP2234978A1 Carbamoyl compounds as dgat1 inhibitors 190
10/06/2010EP1272492B1 Method for producing triethylene diamine, using ethylene diamine
10/06/2010CN101851213A Synthetic methods of 3,6-bis(4-bisfumaroyl aminobutyl)-2,5-diketopiperazine and salt substitute thereof
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807834 Capped pyrazinoylguanidine sodium channel blockers
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807677 1-[N'-[(R)-4-Hydroxy-4-((1S,2R)-2-hydroxy-indan-1-yl]carbamoyl)-5-phenyl-pentyl]-N'-(4-pyridin-4-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl-carbamic acid methyl ester; effective against strains resistant to squinavir, ritonavir, and indinavir; improved bioavailability
09/2010
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249411 Stereoselective Alkylation of Chiral 2-Methly-4 Protected Piperazines
09/30/2010US20100249405 Organic Compounds
09/30/2010US20100249387 Process for producing coelenteramide or an analog thereof
09/30/2010US20100249349 Novel Polymers
09/30/2010US20100249144 Substituted piperazines as cb1 antagonists
09/30/2010US20100249143 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249117 Factor xa inhibitors
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100244671 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using Quinoxaline Derivative
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2232608A1 Light-emitting element, light-emitting device, and electronic device
09/29/2010EP2231680A2 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
09/29/2010EP2231601A2 Glycine transporter-1 inhibitors
09/29/2010EP2231280A2 Organic compounds
09/29/2010CN101848899A N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
09/29/2010CN101843619A Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
09/28/2010US7803898 2,3-di(2-thienyl)-5-(4-aminophenyl)-aminoquinoxaline; N-4-aminophenyl-10-aminodibenzo(A,C)phenazine; polyamines obtained by polymerizing the aminoquinoxaline compound; poly{2,3-diphenyl-5-(4-aminophenyl)-aminoquinoxaline; films, solar cell, oraganic light emitter; semiconductor
09/28/2010US7803802 used in the treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, and their use as inhibitors of the Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010US20100240894 Method for producing amines from glycerin
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100237773 Carbazole Derivative with Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative with Heteroaromatic Ring
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/22/2010EP2229362A1 Piperazines as anti-obesity agents
09/22/2010EP1796669B1 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/22/2010CN101842361A Pyrazinone derivatives and their use in the treatment of lung diseases
09/22/2010CN101842350A New non-peptide derivatives as bradykinin Bl antagonists
09/22/2010CN101842346A Method for producing amines from sugar alcohols
09/22/2010CN101842345A Method for producing amines from glycerin
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010CA2481229C Substituted pyrazine inhibitors of akt
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2405002C Antitumoral analogs of et-743
09/16/2010WO2010104727A1 Compositions and methods for inhibiting the agglomeration of hydrates in a process
09/16/2010WO2010102848A1 Cyclopentadione derived herbicides
09/16/2010US20100234392 4-sulfonylpiperidine derivatives
09/16/2010US20100234391 N-substituted piperazines
09/16/2010US20100234390 Novel compound and their use
09/16/2010US20100234389 Amide compound
09/16/2010US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
09/16/2010CA2754468A1 Compositions and methods for inhibiting the agglomeration of hydrates in a process
09/16/2010CA2750446A1 Cyclopentadione derived herbicides
09/15/2010EP2227770A2 Prolyl hydroxylase inhibitors
09/15/2010CN101835761A Substituted piperazines
09/15/2010CN101829602A Catalytic system for preparing N-Boc-aromatic amine compounds and preparation method and application thereof
09/14/2010US7795429 emit phosphorescence is disclosed. Further, a light-emitting element having good chromaticity is disclosed. An embodiment of the present invention is an organometallic complex including a structure as represented by the general formula (1): wherein R1 represents an alkyl group having 1 to 4 carbon atoms
09/14/2010US7795266 Tetrahydroindolone derivatives for treament of neurological conditions
09/14/2010US7795262 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/14/2010US7795257 Organic compounds
09/14/2010CA2536144C Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
09/10/2010WO2010101853A1 Compositions containing amide surfactants and methods for inhibiting the formation of hydrate agglomerates
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010CA2754016A1 Compositions containing amide surfactants and methods for inhibiting the formation of hydrate agglomerates
09/09/2010US20100228029 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application
09/09/2010US20100228026 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100227902 Bis-aryl sulfonamides
09/09/2010US20100227870 Novel Compounds
09/09/2010US20100226882 Linked diimidazole antivirals
09/09/2010US20100226597 Bortezomib and process for producing same
09/08/2010CN1974560B Compound 3-isopropyl-6-(2-methylbutyl) piperazine-2,5-dione and its preparation and application
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/07/2010US7790722 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders
09/02/2010WO2010067078A8 3,6-disubstituted xanthylium salts
09/02/2010US20100222588 Method for Manufacture of 2-Oxoimidazolidines
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222355 Quinolizidinone m1 receptor positive allosteric modulators
09/02/2010US20100222341 Piperidine and piperazine derivatives
09/02/2010US20100222330 New Compounds
09/02/2010US20100221315 Vesicular formulations containing organic acid prodrugs, process for their preparation
09/02/2010US20100221189 Contrast agents
09/01/2010EP2222650A1 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor
09/01/2010EP2038260B1 Stereoselective synthesis of (s)-1-methyl-3-phenylpiperazine
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 187